People: Illumina Inc (ILMN.O)
Mr. Charles E. Dadswell is Senior Vice President, General Counsel, Secretary of Illumina, Inc., since April 22, 2013. Mr. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. In this role, he was responsible for global intellectual property matters and legal matters in North and Latin America. Prior to bioMerieux, he was General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline. Mr. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelor's in science from Ferris State University.
|Total Annual Compensation, USD||235,577|
|Restricted Stock Awards, USD||2,273,700|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||197,728|
|Fiscal Year Total, USD||2,707,000|